Cargando…
Therapeutic Efficacy of Lactonic Sophorolipids: Nanoceria-Assisted Combination Therapy of NSCLC using HDAC and Hsp90 Inhibitors
Purpose: Non-Small-Cell Lung Cancer (NSCLC) has gained resistance to common chemo- and radiotherapy due to the oncogenic K-RAS mutations. In this work, lactonic sophorolipids (LSL), a constituent of natural sophorolipids known to inhibit histone deacetylase (HDAC) activity, is used to evaluate its p...
Autores principales: | Naz, Shuguftha, Banerjee, Tuhina, Totsingan, Filbert, Woody, Kalee, Gross, Richard A., Santra, Santimukul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077971/ https://www.ncbi.nlm.nih.gov/pubmed/33912379 http://dx.doi.org/10.7150/ntno.57675 |
Ejemplares similares
-
Structure–Activity Relationship Assessment of Sophorolipid Ester Derivatives against Model Bacteria Strains
por: Totsingan, Filbert, et al.
Publicado: (2021) -
Lactonic Sophorolipids Increase Tumor Burden in Apc(min+/-) Mice
por: Callaghan, Breedge, et al.
Publicado: (2016) -
Zika: An emerging disease requiring prevention and awareness
por: Elliott, Rebekah, et al.
Publicado: (2018) -
Comparison of inhibitory effects and mechanisms of lactonic sophorolipid on different pathogenic bacteria
por: Ma, Xiao-jing, et al.
Publicado: (2022) -
Nanomedicine-Assisted Combination Therapy of NSCLC: New Platinum-Based Anticancer Drug Synergizes the Therapeutic Efficacy of Ganetespib
por: Kallu, Jyothi, et al.
Publicado: (2019)